Open Access
Ann Toxicol Anal
Volume 23, Numéro 1, 2011
Page(s) 21 - 35
Publié en ligne 15 juin 2011
  1. Giroud C, Bollmann M, Thomas A, Mangin P, Favrat B. Cannabis: what are the risks? Ann Toxicol Anal. 2009; 20(4): 183-205. [CrossRef] [EDP Sciences] [Google Scholar]
  2. Garrett ER, Hunt CA. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. J Pharm Sci. 1974; 63(7): 1056-1064. [CrossRef] [PubMed] [Google Scholar]
  3. Spahn-Langguth H, Benet LZ. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev. 1992; 24(1): 5-47. [CrossRef] [PubMed] [Google Scholar]
  4. Jamey C, Szwarc E, Tracqui A, Ludes B. Determination of cannabinoids in whole blood by UPLC-MS-MS. J Anal Toxicol. 2008; 32(5): 349-354. [CrossRef] [PubMed] [Google Scholar]
  5. Schwilke EW, Schwope DM, Karschner EL, Lowe RH, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clin Chem. 2009; 55(12): 2180-2189. [CrossRef] [PubMed] [Google Scholar]
  6. Samyn N, Areschka A, Kintz P. Place of oral fluid and hair for workplace drug testing. Ann Toxicol Anal. 2002; 14(1): 33-42. [CrossRef] [EDP Sciences] [Google Scholar]
  7. Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit. 2006; 28(2): 155-163. [CrossRef] [PubMed] [Google Scholar]
  8. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol. 2010; 34(4): 216-221. [PubMed] [Google Scholar]
  9. Thomas A, Deglon J, Steimer T, Mangin P, Daali Y, Staub C. On-line desorption of dried blood spots coupled to hydrophilic interaction/reversed-phase LC/MS/MS system for the simultaneous analysis of drugs and their polar metabolites. J Sep Sci. 2010; 33(6-7): 873-879. [CrossRef] [PubMed] [Google Scholar]
  10. Skopp G, Potsch L. Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin Chem. 2002; 48(2): 301-306. [PubMed] [Google Scholar]
  11. Thomas A, Widmer C, Hopfgartner G, Staub C. Fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood. J Pharm Biomed Anal. 2007; 45(3): 495-503. [CrossRef] [PubMed] [Google Scholar]
  12. Del Mar Ramirez Fernandez M, De Boeck G, Wood M, Lopez-Rivadulla M, Samyn N. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 875(2): 465-470. [CrossRef] [PubMed] [Google Scholar]
  13. König S, Aebi B, Lanz S, Gasser M, Weinmann W. On-line SPE LC-MS/MS for the quantification of Delta9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2011; 400(1): 9-16. [CrossRef] [PubMed] [Google Scholar]
  14. Elian AA, Hackett J. Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2009; 33(8): 461-468. [CrossRef] [PubMed] [Google Scholar]
  15. Jung J, Kempf J, Mahler H, Weinmann W. Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS. J Mass Spectrom. 2007; 42(3): 354-360. [CrossRef] [PubMed] [Google Scholar]
  16. Skopp G, Potsch L. Cannabinoid concentrations in spot serum samples 24–48 h after discontinuation of cannabis smoking. J Anal Toxicol. 2008; 32(2): 160-164. [PubMed] [Google Scholar]
  17. Chebbah C, Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT. Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. Rapid Commun Mass Spectrom. 2010; 24(8): 1133-1141. [CrossRef] [PubMed] [Google Scholar]
  18. Chiarotti M, Costamagna L. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography tandem mass spectrometry (GC/MS-MS). Forensic Sci Int. 2000; 114(1): 1-6. [CrossRef] [PubMed] [Google Scholar]
  19. Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC. Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem. 2009; 42(15): 1531-1542. [CrossRef] [PubMed] [Google Scholar]
  20. Fernandez Mdel M, Wille SM, Samyn N, Wood M, Lopez-Rivadulla M, De Boeck G. On-line solid-phase extraction combined with liquid chromatography-tandem mass spectrometry for high throughput analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(22): 2153-2157. [CrossRef] [PubMed] [Google Scholar]
  21. Grauwiler SB, Scholer A, Drewe J. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts, J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 850(1-2): 515-522. [CrossRef] [PubMed] [Google Scholar]
  22. Schwilke EW, Gullberg RG, Darwin WD, Chiang CN, Cadet JL, Gorelick DA, Pope HG, Huestis MA. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction. 2010; 106(3): 499-506. [CrossRef] [PubMed] [Google Scholar]
  23. Kemp P, Abukhalaf IK, Manno JE, Manno BR, Alford DD, McWilliams ME, Nixon FE, Fitzgerald MJ, Reeves RR, MJ W. Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine. J Anal Toxicol. 1995; 19: 292-298. [Google Scholar]
  24. Felli M, Martello S, Chiarotti M. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests. Forensic Sci Int. 2010; 204(1-3): 67-73. [CrossRef] [PubMed] [Google Scholar]
  25. Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol. 2001; 25(5): 289-303. [PubMed] [Google Scholar]
  26. Emidio ES, de Menezes Prata V, de Santana FJ, Dorea HS. Hollow fiber-based liquid phase microextraction with factorial design optimization and gas chromatography-tandem mass spectrometry for determination of cannabinoids in human hair. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878(24): 2175-2183. [CrossRef] [PubMed] [Google Scholar]
  27. Emidio ES, Prata Vde M, Dorea HS. Validation of an analytical method for analysis of cannabinoids in hair by headspace solid-phase microextraction and gas chromatography-ion trap tandem mass spectrometry. Anal Chim Acta. 2010; 670(1-2): 63-71. [CrossRef] [PubMed] [Google Scholar]
  28. Gambelunghe C, Rossi R, Ferranti C, Bacci M. Hair analysis by GC/MS/MS to verify abuse of drugs. J Appl Toxicol. 2005; 25(3): 205-211. [CrossRef] [PubMed] [Google Scholar]
  29. Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML. Cannabinoid concentrations in hair from documented cannabis users. Forensic Sci Int. 2007; 169(2-3): 129-136. [CrossRef] [PubMed] [Google Scholar]
  30. Lachenmeier DW, Kroener L, Musshoff F, Madea B. Application of tandem mass spectrometry combined with gas chromatography and headspace solid-phase dynamic extraction for the determination of drugs of abuse in hair samples. Rapid Commun Mass Spectrom. 2003; 17(5): 472-478. [CrossRef] [PubMed] [Google Scholar]
  31. Marsili R, Martello S, Felli M, Fiorina S, Chiarotti M. Hair testing for delta9-THC-COOH by gas chromatography/tandem mass spectrometry in negative chemical ionization mode. Rapid Commun Mass Spectrom. 2005; 19(11): 1566-1568. [CrossRef] [PubMed] [Google Scholar]
  32. Coulter C, Taruc M, Tuyay J, Moore C. Quantitation of tetrahydrocannabinol in hair using immunoassay and liquid chromatography with tandem mass spectrometric detection. Drug Test Anal. 2009; 1(5): 234-239. [CrossRef] [PubMed] [Google Scholar]
  33. Kim JY, In MK. Determination of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using gas chromatography/tandem mass spectrometry in negative ion chemical ionization mode. Rapid Commun Mass Spectrom. 2007; 21(7): 1339-1342. [CrossRef] [PubMed] [Google Scholar]
  34. Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D. Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int. 2007; 170(1): 46-50. [CrossRef] [PubMed] [Google Scholar]
  35. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol. 2008; 32(6): 393-401. [CrossRef] [PubMed] [Google Scholar]
  36. Moore C, Vincent M, Rana S, Coulter C, Agrawal A, Soares J. Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device. Forensic Sci Int. 2006; 164(2-3): 126-130. [CrossRef] [PubMed] [Google Scholar]
  37. Quintela O, Crouch DJ, Andrenyak DM. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device. J Anal Toxicol. 2006; 30(8): 614-616. [PubMed] [Google Scholar]
  38. Document consulté le 20 décembre sur le site [Google Scholar]
  39. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003; 42(4): 327-360. [CrossRef] [PubMed] [Google Scholar]
  40. Prestifilippo JP, Fernandez-Solari J, Medina V, Rettori V, Elverdin JC. Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion. Alcohol Alcohol. 2009; 44(5): 443-448. [CrossRef] [PubMed] [Google Scholar]
  41. Day D, Kuntz DJ, Feldman M, Presley L. Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol. 2006; 30(9): 645-650. [PubMed] [Google Scholar]
  42. Laloup M, Ramirez Fernandez Mdel M, Wood M, De Boeck G, Henquet C, Maes V, Samyn N. Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2005; 1082(1): 15-24. [CrossRef] [PubMed] [Google Scholar]
  43. Ristimaa J, Gergov M, Pelander A, Halmesmaki E, Ojanpera I. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry. Anal Bioanal Chem. 2010; 398(2): 925-935. [CrossRef] [PubMed] [Google Scholar]
  44. Poklis JL, Thompson CC, Lichtman AH, Poklis A. Disposition of cannabichromene, cannabidiol and delta-9-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2010; 34: 516-520. [PubMed] [Google Scholar]
  45. Coles R, Clements TT, Nelson GJ, McMillin GA, Urry FM. Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC-MS. J Anal Toxicol. 2005; 29(6): 522-527. [PubMed] [Google Scholar]
  46. ElSohly MA, Feng S. delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC. J Anal Toxicol. 1998; 22(4): 329-335. [PubMed] [Google Scholar]
  47. Feng S, ElSohly MA, Salamone S, Salem MY. Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure. J Anal Toxicol. 2000; 24(6): 395-402. [PubMed] [Google Scholar]
  48. Marchei E, Pellegrini M, Pacifici R, Palmi I, Lozano J, Garcia-Algar O, Pichini S. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the “meconium project”. Ther Drug Monit. 2006; 28(5): 700-706. [PubMed] [Google Scholar]
  49. Moore C, Lewis D, Becker J, Leikin J. The determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in meconium. J Anal Toxicol. 1996; 20(1): 50-51. [PubMed] [Google Scholar]
  50. Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, Smith ML. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Sci Int. 2008; 174(2-3): 173-177. [CrossRef] [PubMed] [Google Scholar]
  51. Lin DL, Lin RL. Distribution of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in traffic fatality cases. J Anal Toxicol. 2005; 29(1): 58-61. [PubMed] [Google Scholar]
  52. Goessaert AS, Pil K, Veramme J, Verstraete A. Analytical evaluation of a rapid on-site oral fluid drug test. Anal Bioanal Chem. 2010; 396(7): 2461-2468. [CrossRef] [PubMed] [Google Scholar]
  53. Oiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem. 2007; 53(2): 300-309. [CrossRef] [PubMed] [Google Scholar]
  54. Quintela O, Andrenyak DM, Hoggan AM, Crouch DJ. A validated method for the detection of Delta 9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta 9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol. 2007; 31(3): 157-164. [PubMed] [Google Scholar]
  55. Sergi M, Bafile E, Compagnone D, Curini R, D’Ascenzo G, Romolo FS. Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS. Anal Bioanal Chem. 2009; 393(2): 709-718. [CrossRef] [PubMed] [Google Scholar]
  56. Simoes SS, Ajenjo AC, Franco JM, Vieira DN, Dias MJ. Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid. Rapid Commun Mass Spectrom. 2009; 23(10): 1451-1460. [CrossRef] [PubMed] [Google Scholar]
  57. Coulter C, Miller E, Crompton K, Moore C. Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2008; 32(8): 653-658. [PubMed] [Google Scholar]
  58. Maralikova B, Weinmann W. Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 2004; 39(5): 526-531. [CrossRef] [PubMed] [Google Scholar]
  59. Jagerdeo E, Montgomery MA, Karas RP, Sibum M. A fast method for screening and/or quantitation of tetrahydrocannabinol and metabolites in urine by automated SPE/LC/MS/MS. Anal Bioanal Chem. 2010; 398(1): 329-338. [CrossRef] [PubMed] [Google Scholar]
  60. Robandt PV, Klette KL, Sibum M. Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory. J Anal Toxicol. 2009; 33(8): 456-460. [PubMed] [Google Scholar]
  61. Weinmann W, Goerner M, Vogt S, Goerke R, Pollak S. Fast confirmation of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). Forensic Sci Int. 2001; 121(1-2): 103-107. [CrossRef] [PubMed] [Google Scholar]
  62. Badawi N, Simonsen KW, Steentoft A, Bernhoft IM, Linnet K. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clin Chem. 2009; 55(11): 2004-2018. [CrossRef] [PubMed] [Google Scholar]
  63. Chi E, Cole J. Detecting Marijuana in Saliva. Forensic Magazine. 2010; 7(5): 17-20. [CrossRef] [Google Scholar]
  64. Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008; 391(6): 2329-2338. [CrossRef] [PubMed] [Google Scholar]
  65. Szirmai M, Beck O, Stephansson N, Halldin MM. A GC-MS study of three major acidic metabolites of delta 1-tetrahydrocannabinol. J Anal Toxicol. 1996; 20(7): 573-578. [PubMed] [Google Scholar]
  66. Marquet P. LC-MS and LC-MS/MS theory and instruments applicable to toxicology. Ann Toxicol Anal. 2005; 17(1): 5-12. [CrossRef] [EDP Sciences] [Google Scholar]
  67. Watanabe K, Itokawa Y, Yamaori S, Funahashi T, Kimura T, Kaji T, Usami N, Yamamoto I. Conversion of cannabidiol to delta-9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice. Forensic Toxicol. 2007; 25: 16-21. [CrossRef] [Google Scholar]
  68. Hughes J, Andrenyak D, Crouch D, Slawson M. Abstract : Comparison of LC-MS Ionization Techniques for Cannabinoid Analysis in Blood. J Anal Toxicol. 2003; 27: 191. [Google Scholar]
  69. Simonin J, Salquebre G, Cirimele V, Kintz P. Screening for illicit drugs in oral fluid by LC-MS/MS. Ann Toxicol Anal. 2007; 19(2): 141-150. [CrossRef] [EDP Sciences] [Google Scholar]
  70. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int. 2010; 198(1-3): 31-38. [CrossRef] [PubMed] [Google Scholar]
  71. Kumazawa T, Hasegawa C, Lee X, Sato K. New and unique methods of solid-phase extraction for use before instrumental analysis of xenobiotics in human specimens. Forensic Toxicol. 2010; 28: 61-68. [CrossRef] [Google Scholar]
  72. Robb DB, Blades MW. State-of-the-art in atmospheric pressure photoionization for LC/MS. Anal Chim Acta. 2008; 627(1): 34-49. [CrossRef] [PubMed] [Google Scholar]
  73. Hudson S, Ramsey J, King L, Timbers S, Maynard S, Dargan PI, Wood DM. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. J Anal Toxicol. 2010; 34(5): 252-260. [CrossRef] [PubMed] [Google Scholar]